Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-01 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate |
2001-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6a974ff10b796d2632b9de915e7faac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c90f0f39c2e34834f510f8de0d5eefc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8556fcc14490a6d1bf91f74c6d76cec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0281a5b162f4520c9f61b50dbce0e869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4774c30d6e9f6cbe4653bed7a02580a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5bdaf4a4694243c72dbadda9f03c8e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50536e6b43c48572a06e77631812a43d |
publicationDate |
2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2342040-C |
titleOfInvention |
Anaerobic bacterium as a drug for cancer gene therapy |
abstract |
The present invention provides a bacterium belonging to the genus Bifidobacterium, by which DNA coding for a protein having an antitumor activity or DNA coding for a protein having the activity of converting a precursor of an antitumor substance into the antitumor substance is delivered to tumor tissues specifically under anaerobic conditions thereby expressing the protein encoded by the DNA, as well as a pharmaceutical composition comprising said anaerobic bacterium. |
priorityDate |
2000-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |